CD4 and ovarian carcinoma: Through TIMER online analysis, the association of immune cells with ovarian cancer patients’ cumulative survival was analyzed using a Kaplan-Meier estimate; Fig. 6A showed that patients with higher dendritic cell or CD4 + T cell obtained better cumulative survival.